Theses›Listed companies›KPRX
Kiora Pharmaceuticals
NASDAQ: KPRX · US
Markets it anchors
Market datarefreshed 6 Nov 2026
| Price | 1.44 USD |
|---|---|
| Market value | $6M |
| Revenue, last 12 months | — |
| Forward P/E | -0.6x |
| EV to revenue | — |
| Gross and operating margin | 0% · 0% |
Not advice. Where I hold a position it is disclosed to members, with the reasoning.